NO20073830L - Medikamenter for behandling eller forebygging av fibrotiske sykdommer - Google Patents
Medikamenter for behandling eller forebygging av fibrotiske sykdommerInfo
- Publication number
- NO20073830L NO20073830L NO20073830A NO20073830A NO20073830L NO 20073830 L NO20073830 L NO 20073830L NO 20073830 A NO20073830 A NO 20073830A NO 20073830 A NO20073830 A NO 20073830A NO 20073830 L NO20073830 L NO 20073830L
- Authority
- NO
- Norway
- Prior art keywords
- prevention
- treatment
- fibrotic diseases
- medications
- salts
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- 230000003176 fibrotic effect Effects 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 238000002483 medication Methods 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 2
- JYGFTBXVXVMTGB-UHFFFAOYSA-N indolin-2-one Chemical class C1=CC=C2NC(=O)CC2=C1 JYGFTBXVXVMTGB-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04030769 | 2004-12-24 | ||
PCT/EP2005/057013 WO2006067175A1 (en) | 2004-12-24 | 2005-12-21 | Medicaments for the treatment or prevention of fibrotic diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20073830L true NO20073830L (no) | 2007-07-23 |
Family
ID=35717457
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20073830A NO20073830L (no) | 2004-12-24 | 2007-07-23 | Medikamenter for behandling eller forebygging av fibrotiske sykdommer |
Country Status (26)
Country | Link |
---|---|
US (3) | US20060148883A1 (sr) |
EP (1) | EP1835907B1 (sr) |
JP (1) | JP5748386B2 (sr) |
KR (1) | KR20070092305A (sr) |
CN (1) | CN101087604B (sr) |
AR (1) | AR052439A1 (sr) |
AT (1) | ATE429222T1 (sr) |
AU (1) | AU2005318136B2 (sr) |
BR (1) | BRPI0519351A2 (sr) |
CA (1) | CA2591089C (sr) |
DE (1) | DE602005014145D1 (sr) |
DK (1) | DK1835907T3 (sr) |
EA (1) | EA200701181A1 (sr) |
ES (1) | ES2326277T3 (sr) |
HR (1) | HRP20090312T1 (sr) |
IL (1) | IL184124A0 (sr) |
MX (1) | MX2007007676A (sr) |
NO (1) | NO20073830L (sr) |
PE (1) | PE20061155A1 (sr) |
PL (1) | PL1835907T3 (sr) |
PT (1) | PT1835907E (sr) |
RS (1) | RS50833B (sr) |
SI (1) | SI1835907T1 (sr) |
TW (1) | TW200637544A (sr) |
WO (1) | WO2006067175A1 (sr) |
ZA (1) | ZA200703600B (sr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7169936B2 (en) * | 2002-07-23 | 2007-01-30 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Indolinone derivatives substituted in the 6-position, their preparation and their use as medicaments |
US7514468B2 (en) * | 2002-07-23 | 2009-04-07 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions |
PE20060777A1 (es) | 2004-12-24 | 2006-10-06 | Boehringer Ingelheim Int | Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas |
WO2007057399A2 (en) * | 2005-11-15 | 2007-05-24 | Boehringer Ingelheim International Gmbh | Treatment of cancer with indole derivatives |
MY150753A (en) * | 2007-03-02 | 2014-02-28 | Mitsui Chemicals Inc | Non-woven fabric laminate |
WO2009063028A2 (en) * | 2007-11-15 | 2009-05-22 | Boehringer Ingelheim International Gmbh | Substituted amides, manufacturing and use thereof as medicaments |
US20090131359A1 (en) * | 2007-11-19 | 2009-05-21 | Atamas Sergei P | Antifibrotic therapy |
RU2010135198A (ru) * | 2008-01-25 | 2012-02-27 | Бёрингер Ингельхайм Интернациональ Гмбх (De) | Солевые формы производного 6-фтор-1,2-дигидро-2-оксо-3н-индол-3-илидена, способ их получения и содержащие их фармацевтические композиции |
US8759010B2 (en) | 2008-09-26 | 2014-06-24 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Host cell kinases as targets for antiviral therapies against HCV infection |
US20140050728A1 (en) * | 2011-01-28 | 2014-02-20 | Board Of Regents Of The University Of Nebraska | Methods and compositions for inhibiting cyclophilin d for the treatment and prevention of obesity and kidney indications |
US10450295B2 (en) | 2013-08-09 | 2019-10-22 | Acclaim BioMed USA LLC | Method of using an indolinone molecule and derivatives for inhibiting liver fibrosis and hepatitis |
US10342786B2 (en) | 2017-10-05 | 2019-07-09 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD |
BR112020006677A2 (pt) | 2017-10-05 | 2020-10-06 | Fulcrum Therapeutics, Inc. | uso de inibidores p38 para reduzir a expressão de dux4 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP0104973A3 (en) * | 1998-09-25 | 2002-06-28 | Boehringer Ingelheim Pharma | Novel substituted indolinones with an inhibitory effect on various kinases and cyclin/cdk complexes, process for their use and medicaments containing them |
US6762180B1 (en) * | 1999-10-13 | 2004-07-13 | Boehringer Ingelheim Pharma Kg | Substituted indolines which inhibit receptor tyrosine kinases |
DE10117204A1 (de) * | 2001-04-06 | 2002-10-10 | Boehringer Ingelheim Pharma | In 6-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel |
PE20040701A1 (es) * | 2002-07-23 | 2004-11-30 | Boehringer Ingelheim Pharma | Derivados de indolinona sustituidos en posicion 6 y su preparacion como medicamentos |
US7169936B2 (en) * | 2002-07-23 | 2007-01-30 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Indolinone derivatives substituted in the 6-position, their preparation and their use as medicaments |
-
2005
- 2005-12-16 PE PE2005001477A patent/PE20061155A1/es not_active Application Discontinuation
- 2005-12-20 US US11/275,226 patent/US20060148883A1/en not_active Abandoned
- 2005-12-21 RS RSP-2009/0245A patent/RS50833B/sr unknown
- 2005-12-21 EA EA200701181A patent/EA200701181A1/ru unknown
- 2005-12-21 CA CA2591089A patent/CA2591089C/en not_active Expired - Fee Related
- 2005-12-21 MX MX2007007676A patent/MX2007007676A/es active IP Right Grant
- 2005-12-21 ES ES05823903T patent/ES2326277T3/es active Active
- 2005-12-21 BR BRPI0519351-6A patent/BRPI0519351A2/pt not_active IP Right Cessation
- 2005-12-21 AT AT05823903T patent/ATE429222T1/de active
- 2005-12-21 PL PL05823903T patent/PL1835907T3/pl unknown
- 2005-12-21 WO PCT/EP2005/057013 patent/WO2006067175A1/en active Application Filing
- 2005-12-21 SI SI200530719T patent/SI1835907T1/sl unknown
- 2005-12-21 KR KR1020077017059A patent/KR20070092305A/ko not_active Application Discontinuation
- 2005-12-21 EP EP05823903A patent/EP1835907B1/en active Active
- 2005-12-21 AU AU2005318136A patent/AU2005318136B2/en not_active Ceased
- 2005-12-21 PT PT05823903T patent/PT1835907E/pt unknown
- 2005-12-21 DK DK05823903T patent/DK1835907T3/da active
- 2005-12-21 CN CN2005800446331A patent/CN101087604B/zh not_active Expired - Fee Related
- 2005-12-21 JP JP2007547510A patent/JP5748386B2/ja not_active Expired - Fee Related
- 2005-12-21 DE DE602005014145T patent/DE602005014145D1/de active Active
- 2005-12-22 AR ARP050105467A patent/AR052439A1/es unknown
- 2005-12-23 TW TW094146423A patent/TW200637544A/zh unknown
-
2007
- 2007-05-04 ZA ZA200703600A patent/ZA200703600B/en unknown
- 2007-06-21 IL IL184124A patent/IL184124A0/en unknown
- 2007-07-23 NO NO20073830A patent/NO20073830L/no not_active Application Discontinuation
-
2009
- 2009-05-27 HR HR20090312T patent/HRP20090312T1/xx unknown
-
2011
- 2011-03-31 US US13/077,138 patent/US20120004202A1/en not_active Abandoned
-
2014
- 2014-01-13 US US14/153,542 patent/US20140128409A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE602005014145D1 (de) | 2009-06-04 |
AU2005318136B2 (en) | 2012-02-09 |
KR20070092305A (ko) | 2007-09-12 |
ZA200703600B (en) | 2008-07-30 |
WO2006067175A1 (en) | 2006-06-29 |
JP5748386B2 (ja) | 2015-07-15 |
US20120004202A1 (en) | 2012-01-05 |
AU2005318136A1 (en) | 2006-06-29 |
CA2591089C (en) | 2014-02-11 |
CA2591089A1 (en) | 2006-06-29 |
ATE429222T1 (de) | 2009-05-15 |
SI1835907T1 (sl) | 2009-10-31 |
EP1835907B1 (en) | 2009-04-22 |
HRP20090312T1 (en) | 2009-07-31 |
IL184124A0 (en) | 2007-10-31 |
US20060148883A1 (en) | 2006-07-06 |
PT1835907E (pt) | 2009-06-16 |
JP2008525374A (ja) | 2008-07-17 |
CN101087604B (zh) | 2010-10-13 |
CN101087604A (zh) | 2007-12-12 |
PL1835907T3 (pl) | 2009-08-31 |
EP1835907A1 (en) | 2007-09-26 |
PE20061155A1 (es) | 2006-12-16 |
AR052439A1 (es) | 2007-03-21 |
BRPI0519351A2 (pt) | 2009-01-20 |
US20140128409A1 (en) | 2014-05-08 |
DK1835907T3 (da) | 2009-08-03 |
TW200637544A (en) | 2006-11-01 |
MX2007007676A (es) | 2007-08-14 |
EA200701181A1 (ru) | 2008-02-28 |
RS50833B (sr) | 2010-08-31 |
ES2326277T3 (es) | 2009-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20073830L (no) | Medikamenter for behandling eller forebygging av fibrotiske sykdommer | |
WO2006067165A3 (en) | Indolidone derivatives for the treatment or prevention of fibrotic diseases | |
DE602006009095D1 (en) | Diacylglycerol-acyltransferase-hemmer | |
WO2006005609A3 (de) | Substituierte oxindol-derivate und diese enthaltende arzneimittel | |
NO20055649L (no) | Substituert dihydrokinazolin med antiviale egenskaper | |
NO20085064L (no) | 4,5-difenyl-pyrimidinyl-oksy eller -merkaptosubstituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter | |
WO2006072458A3 (de) | Substituierte oxindol-derivate, diese enthaltende arzneimittel und deren verwendung | |
TW200609227A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
NO20070224L (no) | 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav | |
NO20091893L (no) | Nye 1,4-benzotiepin-1,1-dioksidderivater som er substituert med benzylgrupper, fremgangsmater for fremstilling av medisiner inneholdende forbindelsene og anvendelse derav. | |
NO20082096L (no) | Azaindol-2-karboksamidderivativer | |
TW200635595A (en) | Medicaments for the treatment of prevention of fibrotic diseases | |
NO20072608L (no) | Biaryloksymetylarenkarboksylsyrer | |
NO20083863L (no) | Pyrazoler som 11-beta-hsd-1 | |
NO20084129L (no) | Pyridin(3,4-B)Pyrazinoner | |
IS2696B (is) | Setin 2-amínótetralín fyrir meðhöndlunina á geðdeyfð | |
IS8485A (is) | Notkun á setnum 2-amínótetralínum í fyrirbyggjandi meðferð á Parkinsons-veiki | |
NO20065926L (no) | Substituerte oksazolbenzoisotiazoldioksidderivater samt fremgangsmate for fremstilling og anvendelse derav | |
NO20074872L (no) | Pyrazoler | |
NO20054408L (no) | 3(2-fenyl-oksazol-4-yl-metoksy)-cykloheksylmetoksyeddiksyrederivater og lignende forbindelser som PPAR-modulatorer for behandling av type 2 diabetes og arterosklerose | |
NO20065880L (no) | 3-Amino-l-arylpropylindoler som monoamin-gjenopptagelsesinhibitor | |
NO20052730L (no) | Aminoalkosyindoler som 5-HT6-reseptorligander for behandling av CNS-lidelser | |
SE0401345D0 (sv) | Therapeutic compounds: Pyridine as scaffold | |
NO20083058L (no) | Cykloheksylsulfonamidderivater med H3 reseptor aktivitet | |
NO20050667L (no) | N-substituerte-1H-indol-5-propionsyreforbindelser som PPAR agonister nyttige for behandling av diabetes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |